Skip to player
Skip to main content
Skip to footer
Search
Connect
Watch fullscreen
Like
Comments
Bookmark
Share
Add to Playlist
Report
This Is The One US Cannabis Stock We Are Watching Today - $MRMD $IIPR $HITI $CGC
Benzinga
Follow
8/3/2023
Welcome to Cannabis Daily - Your daily guide to cannabis news!
Sign up to the cannabis newsletter here https://www.benzinga.com/cannabis/newsletter
Stocks to watch: MRMD IIPR HITI CGC
Category
🗞
News
Transcript
Display full video transcript
00:00
- Good morning, good morning my friends.
00:05
Elliot Lane here with Cannabis Daily.
00:07
Hope you all are having an absolutely stellar,
00:09
thirsty Thursday.
00:11
Appreciate everybody tuning in.
00:13
If you're watching live, as always, say hey.
00:15
Love to hear from you.
00:16
If you're listening later on, review us, rate us,
00:18
tell us what you think, what you want to hear about.
00:20
If we don't hear it here, we will make an active effort
00:24
to give you what you want.
00:26
With that being said, we're going to dive
00:27
into some stocks today, some news.
00:29
Definitely a lot happening.
00:30
Earnings season is really just getting rolling.
00:32
And we're going to start over
00:34
with our good friends at Meramed.
00:35
OTC listed MRMD reported their Q2 earnings yesterday
00:40
after the market closed and saw a 6% sequential increase
00:46
to $36.5 million in revenue on the quarter
00:50
for the three months ending in June.
00:52
Adjusted EBITDA somewhat down on the quarter.
00:56
But that being said, I truly believe Meramed
00:59
is one of the cleanest running companies in the space.
01:01
They have one of the best credit ratings.
01:03
They have one of the healthier balance sheets.
01:06
They are well beloved in the market.
01:07
So Meramed, for sure, probably my US stock to watch
01:11
of the day for sure.
01:12
Moving over to the REIT space,
01:15
IIPR on the NYSE beat expectations,
01:19
generated 76.5 million in revenues up 8% year over year.
01:23
Drove net income of approximately $1.44 per share
01:29
for a total of 40.9 million.
01:31
They also had a quarterly dividend
01:33
of $1.80 per common share.
01:36
Pretty good quarter for IIPR.
01:38
IIPR started off the year a little bit eh.
01:41
Some of their people weren't paying.
01:43
People were starting to get really worried.
01:45
They were one of the headlines for the market
01:46
just being terrible in 2023.
01:48
Q2 looking pretty good so far.
01:52
So I will take that all day and again on Sundays.
01:56
In the first six months of operations,
01:58
New York's legal weed market brought in,
02:00
drum roll, $33 million.
02:03
That is six times less than their neighbor
02:07
to the left, New Jersey.
02:09
By comparison, Missouri brought in over $100 million
02:13
in their first month.
02:16
Their first month.
02:17
I mean, there's a lot that New York's regulatory body,
02:23
the OCM, has to handle.
02:25
But man, $33 million in six months
02:27
is not what was promised, that's for sure.
02:30
Federal representatives recommend buying a map
02:33
so you avoid bringing weed
02:35
into national forests in Minnesota.
02:38
Well, make sure you have an atlas handy
02:42
if you are going to smoke weed
02:43
in the great state of Minnesota.
02:44
New Mexico cannabis sales once again on the rise
02:47
as they surpass a previous record
02:49
as they brought in $34 million in the month of July
02:53
per KRQE or kirky.com.
02:57
A few more here.
02:58
Stiefel initiates coverage on Hightide.
03:01
That's H-I-T-I on the NASDAQ with a buy rating
03:03
and price target of $2.50 Canadian.
03:06
Stiefel calls Hightide a Canadian retailer
03:09
trading at a discount.
03:11
Benjamin Rediger, Missouri is the best state market
03:13
in America for at least the next year.
03:16
I tend to agree, man, and honestly,
03:17
the companies working in Missouri are just great.
03:22
I mean, they're running really well.
03:23
I really enjoy Belief Medical, Good Day Farms,
03:26
C3 Industries, Greenlight Dispensary, Missouri Health.
03:29
I mean, they're all run by pretty competent business people.
03:33
So that being said, I expect those companies
03:35
to grow quickly as well.
03:37
Roth MKM also releases a note on Hightide
03:40
calling them the leading Canadian retailer.
03:43
Hightide tailwinds are working in the company's favor
03:46
and they reiterate a buy with a $1.26 US dollar price target.
03:52
AGP says Canopy Growth, CGC on the NASDAQ,
03:55
is a neutral with a $0.60 Canadian dollar price target.
04:00
Wish that was US dollar.
04:02
Wish that was US dollar over $1, but oh well.
04:05
And then last but not least,
04:06
a survey which included responses
04:09
from more than 400 growers across eight US states
04:12
revealed a significant negative sentiment
04:16
toward the market conditions among cultivators.
04:19
A substantial 58% of growers described their feelings
04:23
toward the market as bad or terrible.
04:25
In comparison, a mere 11% reported feeling good or great
04:29
about the current state of affairs
04:31
per Green Market Report this morning.
04:34
Overall, I actually think earnings are going
04:38
relatively well between us, us girls on this podcast.
04:42
MRMD, IIPR both having pretty positive reports.
04:45
Hopefully we see that trend continue here in Q2.
04:48
I know Q2 you always see at least some flat
04:52
or slight growth in these, especially the MSOs,
04:56
but it does seem like they are moving
04:58
really in the right direction right now.
05:00
So I'm gonna take that and hopefully we can build
05:03
on this positive sentiment that seems to be lacking
05:05
on the cultivator side as we also see new stocks
05:10
take some good notes from Roth, from Stiefel,
05:14
and from other institutions like AGP as well.
05:16
With that being said, Elliot Lane here.
05:17
If I'm watching any stocks today,
05:19
I'm gonna see how shareholders react to MRMD and IIPR.
05:21
Keep an eye on MSOS as well as HITI.
05:24
Thanks y'all, really appreciate it.
05:25
We'll do this one more time tomorrow morning
05:28
and then we're gonna be off for the weekend.
05:30
But until then, trade well, invest well,
05:33
no financial advice.
05:34
However, stay tuned to benzinga.com/canibus
05:37
throughout the day for all your news.
05:38
[BLANK_AUDIO]
Recommended
2:09
|
Up next
2 Retail Stocks To Keep On Your Radar With Retail Expert, Ryan Craver, Founder & CEO, Commerce Canal
Benzinga
8/18/2023
3:49
The Dash For Trash Is Back, Meme Stocks Jump - GME AMC
Benzinga
11/29/2023
5:24
Finding Opportunities In The Market - Raghee Horner, Managing Director of Futures at Simpler Trading
Benzinga
8/11/2023
4:12
No Bid For Defensives and What Are The Bond Markets Telling Us? - Cameron Dawson, CFA, Chief Investment Officer, NewEdge Wealth
Benzinga
8/15/2023
4:58
Year End Market Call And Has The Market Reached A Bottom? Tommy Lackey, Managing Partner at Relativity Capital Advisors
Benzinga
11/1/2023
0:48
Harris-Walz and Cannabis Legalization
Benzinga
8/20/2024
13:01
Big Tech, Small Cap Stocks, And The Upcoming Election On Markets
Benzinga
7/22/2024
14:28
Managing Your Wealth (and sanity) In An Election Year - Ryan Detrick, Carson Group
Benzinga
10/25/2024
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
9/29/2023
18:19
The Stock That Blindsided Investors With 50% Jump - $CVX $INTC $PG $XOM $RETA
Benzinga
7/28/2023
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
9/27/2024
9:48
CPI Data Reaction - Blu Putnam, Managing Director and Chief Economist of CME Group
Benzinga
1/11/2024
2:43
Tech Stocks Get Hit On NFLX and TSLA Earnings
Benzinga
7/20/2023
6:39
What turns around the value stocks?
Benzinga
10/18/2023
4:15
Go Woke, Go Broke, ETF and GUNZ ETF, Matthew Tuttle, Tuttle Capital Management
Benzinga
9/25/2023
2:34
Where is the strength and wekness in the market right now? - $ADBE $XOM $KRE
Benzinga
6/6/2023
1:40
Is Managing Volatility Really An Asset Class?
Benzinga
11/2/2023
3:56
AI And Genomics News From The J.P. Morgan Health Conference 2024 - Lis Agosto, Healthcare Analyst At GlobalX ETFs
Benzinga
1/10/2024
1:51
AMC shares traded higher after the company reported better-than-expected Q2 results and a 12.2% increase in theater attendance
Benzinga
8/8/2023
1:04
Here's Why Tech Stocks May Lead The Way Into The End Of The Year
Benzinga
9/12/2024
17:00
Volatility And Momentum In The Market - Cameron Dawson, CIO NewEdge Wealth
Benzinga
7/24/2024
2:50
Why Celsius Holdings Shares Are Trading Lower - $CELH
Benzinga
9/5/2024
4:38
What Does Today’s Quadwitching Mean For The Market?
Benzinga
12/15/2023
5:41
Earnings Highlights & A Huge Upcoming Catalyst For Viking Therapeutics, Mark This Date
Benzinga
10/24/2024
5:13
Is This A Buy The Dip Opportunity In The Stock Market?
Benzinga
6/26/2023